
Venue: Heathrow Marriott Hotel, London
The importance of cybersecurity and the growing potential of blockchain applications need no introduction these days. Anybody with responsibility for security, IT, e-health, medical devices and innovation in the health sector must be prepared to meet the challenges and opportunities presented by both of these elements.
At the Global Cyber Security in Healthcare and Pharma Summit, you will hear experts from international healthcare organisations, academic and companies at the leading edge of technological solutions.
The meeting is co-located with the 2nd Blockchain in Health Congress and the pass will also give you full access to this meeting. In addition, you have the option to attend the H-ISAC (Health Information Sharing and Analysis Center) London Workshop: Healthcare Cybersecurity.
Attendees will have the opportunity to:
This programme creates a collaborative environment in which attendees can create enduring relationships across the healthcare, medical device and pharmaceutical sectors. They will hear case studies, lessons learnt and best practice techniques; analyse strategies and technologies for security management, incident monitoring, detection and response; leave with the knowledge and contacts to build and improve a comprehensive cybersecurity program and accelerate collaboration and adoption of Blockchain within multiple application areas.
Further information: http://www.global-engage.com/event/cybsec-health-summit/?ref=infosec-conferences.com
Risk-!n Conference 2022 took place on 19-20 May in Zürich, Switzerland. GEIGER was presented in a dedicated session that built on the comparison of cyber risks and radioactivity, called 'GEIGER - We make the invisible visible!'.
The IRIS consortium and the European Cyber Security Organisation (ECSO) have the pleasure to invite you to the official IRIS launch event, taking place virtually on the 5th July from 9:30 to 12:30 CET.
Cyberwatching.eu has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 740129. The content of this website does not represent the opinion of the European Commission, and the European Commission is not responsible for any use that might be made of such content. Privacy Policy | Disclaimer / Terms and Conditions of Use